Crespel, A., De Boisvilliers, F., Gros, L
As of 2026, two oral GLP-1 medications are FDA-approved for weight loss: the once-daily Wegovy pill (oral semaglutide 25 mg) and orforglipron (Foundayo)
A new study suggests that people taking GLP-1 medications for diabetes and obesity are reporting additional side effects online that may not be fully captured in clinical trials
Clinical trials show GLP-1 agonists produce significantly greater weight losstypically 1522% of body weight over 68 weekscompared to phentermine's effects
Similar disappointing observations of HIV patients supplemented with NAC were also made by [12] and [13]
On the visit-reason screen, the Weight Management tile explicitly lists the options as GLP-1s, HRT, and lifestyle counseling. That framing is meaningful for women in perimenopause or menopause who are dealing with weight gain that is tangled up with hormonal changes, sleep disruption, and mood shifts Midi treats weight as one thread in a larger midlife-health picture rather than as a standalone prescription transaction